CRMD insider trading
NasdaqGM HealthcareCorMedix Inc.: insider trade history from SEC Form 4 filings.
About CorMedix Inc.
CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for life-threatening diseases and conditions in the United States. Its lead product candidate is DefenCath, an antimicrobial catheter lock solution to reduce the incidence of catheter-related bloodstream infections in adult patients with kidney failure. The company was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. CorMedix Inc. was incorporated in 2006 and is based in Berkeley Heights, New Jersey.
Company website: www.cormedix.com
CRMD insider activity at a glance
FilingIQ tracks 330 insider transactions for CRMD in filings since Jan 2, 2015. The most recent transaction is dated Sep 18, 2026.
Across the full history, 112 open-market purchases
and 55 open-market sales
were filed under transaction codes P and S respectively. Compensatory share awards
(code A) and option exercises (code M) are tracked separately and not counted here.
The average FilingIQ composite score on CRMD insider trades is 59.6/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.
Latest CRMD Form 4 filings
Most recent disclosures. Sign up to filter by score, transaction code, or insider role.
Other Healthcare tickers with recent insider activity
Frequently asked
- How many insider trades does FilingIQ track for CRMD?
- FilingIQ tracks 330 Form 4 insider transactions for CRMD (CorMedix Inc.), covering filings from Jan 2, 2015 onwards. 4 of those are dated within the last 90 days.
- Are CRMD insiders net buyers or net sellers?
- Across the full Form 4 history for CRMD, 112 transactions (34%) were open-market purchases and 55 (17%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
- Where does CRMD insider data come from?
- Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ normalises insider identity across reporting variations and scores discretionary open-market purchases and sales on its multi-factor composite model.
- What sector is CRMD in?
- CorMedix Inc. (CRMD) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $557.43M.
Methodology & sources
Every CRMD insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.